return2ozma@lemmy.world to News@lemmy.world · 9 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square158fedilinkarrow-up1615arrow-down116cross-posted to: anticorporate@lemmy.giftedmc.compiracy@lemmy.dbzer0.comforskning_videnskabnews@beehaw.orgmedicine@mander.xyz
arrow-up1599arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 9 months agomessage-square158fedilinkcross-posted to: anticorporate@lemmy.giftedmc.compiracy@lemmy.dbzer0.comforskning_videnskabnews@beehaw.orgmedicine@mander.xyz
minus-squareblazera@lemmy.worldlinkfedilinkEnglisharrow-up102arrow-down3·9 months agoarticle doesnt present any pressure they are facing. also Drug production costs are often shrouded in secrecy with little clarity on how they relate to prices, if at all. Prices are never about cost, its what people are willing to pay. Which gets brutally exploited by pharmaceutical industry.
minus-squaremelpomenesclevage@lemm.eelinkfedilinkarrow-up1·9 months agoTo be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.
article doesnt present any pressure they are facing. also
Prices are never about cost, its what people are willing to pay. Which gets brutally exploited by pharmaceutical industry.
deleted by creator
To be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.